Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-26

Clinical Trial Update: Study of Refractory and/or Relapsing TAkayasu aRTeritis

View source ↗

Summary

A clinical trial update regarding refractory and relapsing Takayasu arteritis; further status details are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Systemic Vasculitis, Arteritis, Takayasu | Status: UNKNOWN